Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence A Leiter

Showing results (11-20 of 476) with videos related to

Pageof 48
Sort By:
Atherosclerosis. Supplements|March 7, 2006
Optimal care of cardiovascular disease and type 2 diabetes patients: shared responsibilities between the cardiologist and diabetologistLawrence A Leiter, David Fitchett
Diabetes, Obesity & Metabolism|April 20, 2019
Residual cardiovascular risk among people with diabetesSatya Dash, Lawrence A Leiter
Vascular Health and Risk Management|February 27, 2007
Ongoing clinical trials of the pleiotropic effects of statinsJean Davignon, Lawrence A Leiter
The Canadian Journal of Cardiology|August 21, 2012
Drugs targeting high-density lipoprotein cholesterol for coronary artery disease managementPamela M Katz, Lawrence A Leiter
American Journal of Hypertension|February 5, 2005
Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibitionLawrence A Leiter, Richard Z Lewanczuk
Canadian Journal of Diabetes|December 15, 2015
The Role of the Kidney and SGLT2 Inhibitors in Type 2 DiabetesPamela M Katz, Lawrence A Leiter
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 21, 2017
Lawrence A Leiter, Michael A Nauck
Current Medical Research and Opinion|October 9, 2002
Lipids and diabetes mellitus: a review of therapeutic optionsJeannette M Goguen, Lawrence A Leiter
The Canadian Journal of Cardiology|April 28, 2006
Metabolic syndrome under fire: weighing in on the truthA Y Cheng, Lawrence A Leiter
Current Opinion in Cardiology|June 7, 2006
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesAlice Yy Cheng, Lawrence A Leiter
Pageof 48

Showing results (11-20 of 476) with videos related to

Sort By:
Pageof 48
Atherosclerosis. Supplements|March 7, 2006
Optimal care of cardiovascular disease and type 2 diabetes patients: shared responsibilities between the cardiologist and diabetologistLawrence A Leiter, David Fitchett
Diabetes, Obesity & Metabolism|April 20, 2019
Residual cardiovascular risk among people with diabetesSatya Dash, Lawrence A Leiter
Vascular Health and Risk Management|February 27, 2007
Ongoing clinical trials of the pleiotropic effects of statinsJean Davignon, Lawrence A Leiter
The Canadian Journal of Cardiology|August 21, 2012
Drugs targeting high-density lipoprotein cholesterol for coronary artery disease managementPamela M Katz, Lawrence A Leiter
American Journal of Hypertension|February 5, 2005
Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibitionLawrence A Leiter, Richard Z Lewanczuk
Canadian Journal of Diabetes|December 15, 2015
The Role of the Kidney and SGLT2 Inhibitors in Type 2 DiabetesPamela M Katz, Lawrence A Leiter
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 21, 2017
Lawrence A Leiter, Michael A Nauck
Current Medical Research and Opinion|October 9, 2002
Lipids and diabetes mellitus: a review of therapeutic optionsJeannette M Goguen, Lawrence A Leiter
The Canadian Journal of Cardiology|April 28, 2006
Metabolic syndrome under fire: weighing in on the truthA Y Cheng, Lawrence A Leiter
Current Opinion in Cardiology|June 7, 2006
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesAlice Yy Cheng, Lawrence A Leiter
Pageof 48